Clinical Roundup Updated NCCN guidelines will reduce potentially unnecessary breast cancer treatments February 17, 2023Vol.49 No.07
Clinical Roundup Opdivo + Cabometyx shows durable survival in three-year follow-up for first-line advanced RCC February 17, 2023Vol.49 No.07
Clinical Roundup Interim phase II results show positive safety and efficacy data for bel-sar in early-stage choroidal melanoma February 17, 2023Vol.49 No.07
Clinical Roundup Moffitt researchers discover pathways to activate dendritic cells, produce strong anti-tumor immunity February 17, 2023Vol.49 No.07
Clinical Roundup NY Proton Center initiates three studies on FLASH radiation therapy February 17, 2023Vol.49 No.07
Clinical Roundup Lung cancer study finds new target for treatment resistance after EGFR inhibitors February 17, 2023Vol.49 No.07
Clinical Roundup Research reveals why cancers stop responding to kinase-blocking drugs February 17, 2023Vol.49 No.07
Clinical Roundup Keytruda + chemo met primary endpoint as first-line therapy for advanced or recurrent endometrial carcinoma February 10, 2023Vol.49 No.06
Clinical Roundup Oncolytic virus treatment produces promising results for TNBC in phase II study February 10, 2023Vol.49 No.06
